Sanara MedTech Inc.
SMTI
$20.76
$0.391.92%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 101.90M | 97.24M | 91.57M | 86.67M | 78.06M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 101.90M | 97.24M | 91.57M | 86.67M | 78.06M |
| Cost of Revenue | 7.90M | 8.01M | 8.08M | 8.14M | 7.68M |
| Gross Profit | 94.01M | 89.23M | 83.49M | 78.53M | 70.38M |
| SG&A Expenses | 84.77M | 82.31M | 79.71M | 74.46M | 68.91M |
| Depreciation & Amortization | 3.95M | 4.04M | 4.03M | 4.01M | 4.00M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 102.43M | 99.93M | 97.12M | 91.74M | 83.96M |
| Operating Income | -521.70K | -2.68M | -5.55M | -5.07M | -5.90M |
| Income Before Tax | -6.41M | -7.43M | -8.94M | -7.21M | -5.77M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -6.41 | -7.43 | -8.94 | -7.21 | -5.77 |
| Earnings from Discontinued Operations | -31.25M | -2.68M | -2.68M | -2.68M | -2.68M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 167.20K | 167.90K | 189.10K | 223.80K | 87.10K |
| Net Income | -37.49M | -9.94M | -11.43M | -9.66M | -8.36M |
| EBIT | -521.70K | -2.68M | -5.55M | -5.07M | -5.90M |
| EBITDA | 3.48M | 1.76M | -1.12M | -652.60K | -1.49M |
| EPS Basic | -4.34 | -1.16 | -1.34 | -1.14 | -0.99 |
| Normalized Basic EPS | -0.52 | -0.59 | -0.71 | -0.58 | -0.59 |
| EPS Diluted | -4.23 | -1.16 | -1.34 | -1.14 | -0.99 |
| Normalized Diluted EPS | -0.52 | -0.59 | -0.71 | -0.58 | -0.59 |
| Average Basic Shares Outstanding | 34.36M | 34.23M | 34.09M | 33.94M | 33.79M |
| Average Diluted Shares Outstanding | 34.66M | 34.23M | 34.09M | 33.94M | 33.79M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |